Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 May;73(9):1096–1100. doi: 10.1038/bjc.1996.211

A phase II study of cisplatin, vindesine and continuously infused 5-fluorouracil in the treatment of advanced non-small-cell lung cancer. Osaka Lung Cancer Chemotherapy Study Group.

T Nakano 1, H Ikegami 1, S Nakamura 1, T Kawase 1, H Nishikawa 1, S Yokota 1, M Yoshida 1, T Tachibana 1, T Igarashi 1, K Komuta 1, K Higashino 1
PMCID: PMC2074391  PMID: 8624270

Abstract

Fifty-two previously untreated patients with advanced non-small-cell lung cancer (NSCLC) were treated on a 14 day cycle with cisplatin (60 mg m-2 i.v.) and vindesine (3 mg m-2 i.v.) on day 1, followed by a 3 day continuous infusion of 5-fluorouracil (800 mg m-2 day-1) starting on day 8. An overall response rate of 40.4% was observed in 47 evaluable patients, which included one complete response and 18 partial responses. Responses were achieved in 61.1% of stage 3 patients and 27.6% of stage 4 patients. The median progression-free interval was 19.3 weeks, and median survival time was 41.6 weeks (47.1 weeks for patients with stage 3 disease and 38.7 weeks for those with stage 4 disease). Toxicity was well tolerated. Gastrointestinal and renal toxicities did not exceed WHO grade 2. Grade 3 or 4 leucopenia and anaemia occurred in nine (19%) and four (9%) patients respectively, but only grade 2 thrombocytopenia was observed. Phlebitis at the infusion site was observed in 24 patients (53%). This treatment programme achieved a response rate similar to other active combination regimens for the treatment of advanced NSCLC, and was less toxic.

Full text

PDF
1096

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carlson R. W., Sikic B. I. Continuous infusion or bolus injection in cancer chemotherapy. Ann Intern Med. 1983 Dec;99(6):823–833. doi: 10.7326/0003-4819-99-6-823. [DOI] [PubMed] [Google Scholar]
  2. Decker D. A., Drelichman A., Jacobs J., Hoschner J., Kinzie J., Loh J. J., Weaver A., Al-Sarraf M. Adjuvant chemotherapy with cis-diamminodichloroplatinum II and 120-hour infusion 5-fluorouracil in Stage III and IV squamous cell carcinoma of the head and neck. Cancer. 1983 Apr 15;51(8):1353–1355. doi: 10.1002/1097-0142(19830415)51:8<1353::aid-cncr2820510805>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  3. Dhingra H. M., Valdivieso M., Carr D. T., Chiuten D. F., Farha P., Murphy W. K., Spitzer G., Umsawasdi T. Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancer. J Clin Oncol. 1985 Feb;3(2):176–183. doi: 10.1200/JCO.1985.3.2.176. [DOI] [PubMed] [Google Scholar]
  4. Einhorn L. H., Loehrer P. J., Williams S. D., Meyers S., Gabrys T., Nattan S. R., Woodburn R., Drasga R., Songer J., Fisher W. Random prospective study of vindesine versus vindesine plus high-dose cisplatin versus vindesine plus cisplatin plus mitomycin C in advanced non-small-cell lung cancer. J Clin Oncol. 1986 Jul;4(7):1037–1043. doi: 10.1200/JCO.1986.4.7.1037. [DOI] [PubMed] [Google Scholar]
  5. Elliott J. A., Ahmedzai S., Hole D., Dorward A. J., Stevenson R. D., Kaye S. B., Banham S. W., Stack B. H., Calman K. C. Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: a randomized study. Eur J Cancer Clin Oncol. 1984 Aug;20(8):1025–1032. doi: 10.1016/0277-5379(84)90104-4. [DOI] [PubMed] [Google Scholar]
  6. Fukuoka M., Masuda N., Furuse K., Negoro S., Takada M., Matsui K., Takifuji N., Kudoh S., Kawahara M., Ogawara M. A randomized trial in inoperable non-small-cell lung cancer: vindesine and cisplatin versus mitomycin, vindesine, and cisplatin versus etoposide and cisplatin alternating with vindesine and mitomycin. J Clin Oncol. 1991 Apr;9(4):606–613. doi: 10.1200/JCO.1991.9.4.606. [DOI] [PubMed] [Google Scholar]
  7. Fukuoka M., Negoro S., Masuda N., Kusunoki Y., Matsui K., Ryu S., Takifuji N., Kudoh S., Takada M. Mitomycin C, vindesine, and cisplatin in advanced non-small-cell lung cancer. A phase II study. Am J Clin Oncol. 1992 Feb;15(1):18–22. doi: 10.1097/00000421-199202000-00004. [DOI] [PubMed] [Google Scholar]
  8. Gralla R. J., Casper E. S., Kelsen D. P., Braun D. W., Jr, Dukeman M. E., Martini N., Young C. W., Golbey R. B. Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules. Ann Intern Med. 1981 Oct;95(4):414–420. doi: 10.7326/0003-4819-95-4-414. [DOI] [PubMed] [Google Scholar]
  9. Jacobs C., Bertino J. R., Goffinet D. R., Fee W. E., Goode R. L. 24-hour infusion of cis-platinum in head and neck cancers. Cancer. 1978 Nov;42(5):2135–2140. doi: 10.1002/1097-0142(197811)42:5<2135::aid-cncr2820420508>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  10. Joss R. A., Bürki K., Dalquen P., Schatzmann E., Leyvraz S., Cavalli F., Ludwig C., Siegenthaler P., Alberto P., Stahel R. Combination chemotherapy with mitomycin, vindesine, and cisplatin for non-small cell lung cancer. Association of antitumor activity with initial tumor burden and treatment center. Cancer. 1990 Jun 1;65(11):2426–2434. doi: 10.1002/1097-0142(19900601)65:11<2426::aid-cncr2820651104>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  11. Klastersky J., Sculier J. P., Lacroix H., Dabouis G., Bureau G., Libert P., Richez M., Ravez P., Vandermoten G., Thiriaux J. A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861. J Clin Oncol. 1990 Sep;8(9):1556–1562. doi: 10.1200/JCO.1990.8.9.1556. [DOI] [PubMed] [Google Scholar]
  12. Kris M. G., Gralla R. J., Wertheim M. S., Kelsen D. P., O'Connell J. P., Burke M. T., Fiore J. J., Cibas I. R., Heelan R. T. Trial of the combination of mitomycin, vindesine, and cisplatin in patients with advanced non-small cell lung cancer. Cancer Treat Rep. 1986 Sep;70(9):1091–1096. [PubMed] [Google Scholar]
  13. Luedke D. W., Einhorn L., Omura G. A., Sarma P. R., Bartolucci A. A., Birch R., Greco F. A. Randomized comparison of two combination regimens versus minimal chemotherapy in nonsmall-cell lung cancer: a Southeastern Cancer Study Group Trial. J Clin Oncol. 1990 May;8(5):886–891. doi: 10.1200/JCO.1990.8.5.886. [DOI] [PubMed] [Google Scholar]
  14. Lynch T. J., Jr, Clark J. R., Kalish L. A., Fallon B. G., Elias A. D., Skarin A., Frei E., 3rd Continuous-infusion cisplatin, 5-fluorouracil, and bolus methotrexate in the treatment of advanced non-small cell lung cancer. Cancer. 1992 Oct 1;70(7):1880–1885. doi: 10.1002/1097-0142(19921001)70:7<1880::aid-cncr2820700713>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  15. Miles D. W., Earl H. M., Souhami R. L., Harper P. G., Rudd R., Ash C. M., James L., Trask C. W., Tobias J. S., Spiro S. G. Intensive weekly chemotherapy for good-prognosis patients with small-cell lung cancer. J Clin Oncol. 1991 Feb;9(2):280–285. doi: 10.1200/JCO.1991.9.2.280. [DOI] [PubMed] [Google Scholar]
  16. Miller A. B., Hoogstraten B., Staquet M., Winkler A. Reporting results of cancer treatment. Cancer. 1981 Jan 1;47(1):207–214. doi: 10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  17. Miller T. P., Vance R. B., Ahmann F. R., Rodney S. R. Extensive non-small cell lung cancer treated with mitomycin, cisplatin, and vindesine (MiPE): a Southwest Oncology Group Study. Cancer Treat Rep. 1986 Sep;70(9):1101–1104. [PubMed] [Google Scholar]
  18. Mountain C. F. A new international staging system for lung cancer. Chest. 1986 Apr;89(4 Suppl):225S–233S. doi: 10.1378/chest.89.4_supplement.225s. [DOI] [PubMed] [Google Scholar]
  19. Richards F., 2nd, Perry D. J., Goutsou M., Modeas C., Muchmore E., Rege V., Chahinian A. P., Hirsh V., Poiesz B., Green M. R. Chemotherapy with 5-fluorouracil (5-FU) and cisplatin or 5-FU, cisplatin, and vinblastine for advanced non-small cell lung cancer. A randomized phase II study of the cancer and leukemia group B. Cancer. 1991 Jun 15;67(12):2974–2979. doi: 10.1002/1097-0142(19910615)67:12<2974::aid-cncr2820671206>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  20. Rosenthal C. J., Wampler G. L., Brereton H. D., Ahlgren J. D., Lokich J. J., Fryer J. G., Alt D. E. A study of oral etoposide, infusional cisplatin, and infusional 5-fluorouracil for locally advanced or metastatic non-small-cell lung cancer. A Mid-Atlantic Oncology Program study. Am J Clin Oncol. 1992 Feb;15(1):12–17. doi: 10.1097/00000421-199202000-00003. [DOI] [PubMed] [Google Scholar]
  21. Ruckdeschel J. C., Mehta C. R., Salazar O. M., Cohen M., Vogl S., Koons L. S., Lerner H. Chemotherapy for inoperable, non-small cell bronchogenic carcinoma: EST 2575, generation II. Cancer Treat Rep. 1981 Nov-Dec;65(11-12):965–972. [PubMed] [Google Scholar]
  22. Saito Y., Mori K., Tominaga K., Yokoi K., Miyazawa N. Phase II study of 5-day continuous infusion of cis-diamminedichloroplatinum(II) in the treatment of non-small-cell lung cancer. Cancer Chemother Pharmacol. 1990;26(6):389–392. doi: 10.1007/BF02994086. [DOI] [PubMed] [Google Scholar]
  23. Schabel F. M., Jr, Trader M. W., Laster W. R., Jr, Corbett T. H., Griswold D. P., Jr cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice. Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1459–1473. [PubMed] [Google Scholar]
  24. Seifert P., Baker L. H., Reed M. L., Vaitkevicius V. K. Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma. Cancer. 1975 Jul;36(1):123–128. doi: 10.1002/1097-0142(197507)36:1<123::aid-cncr2820360108>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  25. Verweij J., de Jong P. C., de Mulder P. H., van der Broek P., Alexieva-Figusch J., van Putten W. L., Schornagel J. H., Ravasz L. A., Snow G. B., Vermorken J. B. Induction chemotherapy with cisplatin and continuous infusion 5-fluorouracil in locally far-advanced head and neck cancer. Am J Clin Oncol. 1989 Oct;12(5):420–424. doi: 10.1097/00000421-198910000-00012. [DOI] [PubMed] [Google Scholar]
  26. Weiden P. L., Einstein A. B., Rudolph R. H. Cisplatin bolus and 5-FU infusion chemotherapy for non-small cell lung cancer. Cancer Treat Rep. 1985 Nov;69(11):1253–1255. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES